Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_assertion type Assertion NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_head.
- NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_assertion description "[The present data shows that Maitake D-Fraction suppresses the breast tumoral phenotype through a putative molecular mechanism modifying the expression of certain genes (such as IGFBP-7, ITGA2, ICAM3, SOD2, CAV-1, Cul-3, NRF2, Cycline E, ST7, and SPARC) that are involved in apoptosis stimulation, inhibition of cell growth and proliferation, cell cycle arrest, blocking migration and metastasis of tumoral cells, and inducing multidrug sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_provenance.
- NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_assertion evidence source_evidence_literature NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_provenance.
- NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_assertion SIO_000772 23875900 NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_provenance.
- NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_assertion wasDerivedFrom befree-20150227 NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_provenance.
- NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_assertion wasGeneratedBy ECO_0000203 NP416680.RAvlu4KeR8-Xw6Fx6PPUsGHE1GShN0YnBVuT2hArBAOmo130_provenance.